Charles River Laboratories
Company Snapshot
Company Overview
Charles River Laboratories was an early-stage CRO founded in 1947. It has undergone several changes in business structure. Charles River Laboratories International Inc. was incorporated in 1994. The company offers a wide range of services from basic research to discovery, safety, and efficacy to clinical support and manufacturing. These services are offered to customers globally, including leading pharmaceutical and biotechnology companies, agrochemical companies, government, and academic organizations.
The company operates in three reportable segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support. Its broad portfolio of products and services offers compliant drug development models that reduce costs, increase productivity and effectiveness, and increase speed to market.
Financial Highlights (FY 2024)
This information is available for BCC Research members only.
Charles River Laboratories In Reports
Company's Business Segments
- Research Models and Services (RMS) : This segment includes three businesses: Research Models, Research Model Services, and Cell Solutions.
- Discovery and Safety Assessment (DSA) : This segment includes two businesses: Discovery Services and Safety Assessment.
- Manufacturing Solutions (Manufacturing) : This segment includes two businesses: Microbial Solutions and Biologics Solutions.
Applications/End User Industries
- Cardiovascular Diseases
- Immunology
- Infectious Diseases
- Inflammation
- Oncology
- Rare Disease
- Renal Disorders
- Respiratory Disease
- Musculoskeletal Disease
- Metabolic Disease
- Ophthalmology
